Jasgit Sachdev

5PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 12, 2023
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors.

Gerald S Falchook, Jasgit Sachdev, Esteban Rodrigo Imedio

|May 18, 2022
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors.

Pamela N Munster, Andrew E Greenstein, Gini F Fleming

|Jun 04, 2021
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors.

Michael L Maitland, Jasgit C Sachdev, Manish R Sharma

|Nov 17, 2020
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase.

Jasgit C Sachdev, Pamela Munster, Donald W Northfelt

|Nov 05, 2020
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers.

Komal Jhaveri, Matthew T Chang, Dejan Juric

Pageof 1

Frequent Collaborators

1 joint publications

Cristina Saura

1 joint publications

Philippe L Bedard

1 joint publications

Helen Won

1 joint publications

Maurizio Scaltriti